1-5 of 5
Drew Pardoll
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses

Available to Purchase
Meghan B. Davis, David Vasquez-Dunddel, Juan Fu, Emilia Albesiano, Drew Pardoll, Young J. Kim
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 3984–3992.
https://doi.org/10.1158/1078-0432.CCR-10-3262
Published: 15 June 2011
View articletitled, Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
Open the PDF for Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses in another window
Includes: Supplementary data
Journal Articles

A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3

Available to Purchase
Cornelia L. Trimble, Shiwen Peng, Ferdynand Kos, Patti Gravitt, Raphael Viscidi, Elizabeth Sugar, Drew Pardoll, T.C. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 361–367.
https://doi.org/10.1158/1078-0432.CCR-08-1725
Published: 31 December 2008
View articletitled, A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
Open the PDF for A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3 in another window
Journal Articles

HLA-DQB1*02–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial Lesions

Available to Purchase
Shiwen Peng, Cornelia Trimble, Lee Wu, Drew Pardoll, Richard Roden, Chien-Fu Hung, T.-C. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2479–2487.
https://doi.org/10.1158/1078-0432.CCR-06-2916
Published: 16 April 2007
View articletitled, HLA-DQB1*02–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial Lesions
Open the PDF for HLA-DQB1*02–Restricted HPV-16 E7 Peptide–Specific CD4+ T-Cell Immune Responses Correlate with Regression of HPV-16–Associated High-Grade Squamous Intraepithelial Lesions in another window
Includes: Supplementary data
Journal Articles

Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype

Available to Purchase
Cornelia L. Trimble, Steven Piantadosi, Patti Gravitt, Brigitte Ronnett, Ellen Pizer, Andrea Elko, Barbara Wilgus, William Yutzy, Richard Daniel, Keerti Shah, Shiwen Peng, Chienfu Hung, Richard Roden, Tzyy Choou Wu, Drew Pardoll, The Johns Hopkins Medical Institutions, Baltimore, MD
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4717–4723.
https://doi.org/10.1158/1078-0432.CCR-04-2599
Published: 06 July 2005
View articletitled, Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype
Open the PDF for Spontaneous Regression of High-Grade Cervical Dysplasia: Effects of Human Papillomavirus Type and HLA Phenotype in another window
Journal Articles

Recombinant Human Papillomavirus Type 16 E7 Protein as a Model Antigen to Study the Vaccine Potential in Control and E7 Transgenic Mice

Available to Purchase
Catherine M. Gérard, Nathalie Baudson, Kirsty Kraemer, Catherine Ledent, Drew Pardoll, Claudine Bruck
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 838s–847s.
Published: 01 March 2001
View articletitled, Recombinant Human Papillomavirus Type 16 E7 Protein as a Model Antigen to Study the Vaccine Potential in Control and E7 Transgenic Mice
Open the PDF for Recombinant Human Papillomavirus Type 16 E7 Protein as a Model Antigen to Study the Vaccine Potential in Control and E7 Transgenic Mice in another window